Published peptide research references
Beinaglutide
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study.
Source identity and connection checked by Codex (AI).
Obesity in China: current progress and future prospects.
DOI: 10.1016/s2213-8587(25)00357-2PMID: 41389801
Source identity and connection checked by Codex (AI).
The effects of Beinaglutide on obesity and related factors: a systematic review and meta-analysis of randomized controlled trials.
DOI: 10.1080/17446651.2025.2491404
Source identity and connection checked by Codex (AI).
The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open-label, randomized trial.
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Chen K
- Chen L
- Shan Z
- Wang G
- Qu S
- Qin G
- Yu X
- Xin W
- Hsieh TH
- Mu Y
- Liu X
- Yang W
- Liu J
- Huang X
- Fang Y
- Ming J
- Lai J
- Fu J
- Ji Q
- Wang L
- Poshtdar S
- Rohani P
- Ahrabi A
- Panahi N
- Sohouli MH
- Pan XF
- Fang ZZ
- Zhang L
- Pan A